CCl4 cirrhosis in rats: irreversible histological changes and differentiated functional impairment

J Hepatol. 1991 Jan;12(1):110-7. doi: 10.1016/0168-8278(91)90919-3.

Abstract

Cirrhosis of the rat liver was induced by a 12 week individualized CCl4/phenobarbital treatment. After treatment, all surviving animals (81%) showed cirrhosis of the liver. The cirrhosis induced was irreversible when evaluated 24 weeks after cessation of treatment. Quantitative liver function measurements were reduced in a differentiated manner. Ranked according to the most pronounced changes they are: capacity of urea-N synthesis (CUNS), galactose elimination capacity (GEC) and antipyrine clearance (APC). Hepatic glutathione concentrations were only slightly decreased after the CCl4 treatment. It is possible to produce a high incidence of irreversible cirrhosis with differentiated functional impairment in the rat.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antipyrine / metabolism
  • Carbon Tetrachloride / adverse effects*
  • Galactose / metabolism
  • Liver / metabolism
  • Liver / pathology*
  • Liver / physiology
  • Liver Cirrhosis, Experimental / chemically induced*
  • Liver Cirrhosis, Experimental / pathology
  • Liver Cirrhosis, Experimental / physiopathology
  • Male
  • Phenobarbital / adverse effects
  • Rats
  • Rats, Inbred Strains
  • Urea / metabolism

Substances

  • Urea
  • Carbon Tetrachloride
  • Antipyrine
  • Galactose
  • Phenobarbital